Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
KNE.Vthis companyKane Biotech Inc.	CA$0.03	-2.38×	-8.69×	15.17×	-2.68×	-157.1%	-38.2%	-727.4%	-636.0%	364.5%	-192.2%	-50.2%	-3.09×	-0.48×	-12.82×	0.68×	0.0%	3	-28.19	2	C
AVCR.VAvricore Health Inc.	CA$0.05	-2.72×	13×	9.49×	-3.94×	-985.8%	44.3%	-256.1%	-348.2%	-477.1%	-351.0%	-17.9%	0×	0.19×	-151.48×	2.11×	0.0%	2	-12.33	1	D+
HEAL.CNRestart Life Sciences Corp.	CA$0.08	-3.13×	3.29×	0×	-2.15×	-56.8%	0.0%	0.0%	0.0%	-108.0%	-87.8%	-16.9%	0.19×	1.01×	0×	3.67×	0.0%	3	-42.67	2	C
TELO.VTelo Genomics Corp.	CA$0.05	-1.74×	-2.54×	0×	-2.44×	-121.0%	0.0%	0.0%	0.0%	146.0%	1560.7%	-40.1%	-0.91×	-0.53×	-11.44×	0.21×	0.0%	1	-90.75	2	C
TGIF.CN1933 Industries Inc.	CA$0.01	-25×	-1.07×	0.28×	21.83×	-4744.4%	29.6%	3.9%	-1.2%	4.7%	-11.2%	34.0%	-3.83×	16.96×	1.02×	0.84×	0.0%	5	-7.98	2	C
THRM.VTherma Bright Inc.	CA$0.03	-0.9×	-2.51×	48.92×	-0.93×	-266.6%	-46.0%	-2202.6%	-5410.4%	277.3%	115.9%	-3.7%	-0.03×	-0.01×	-677.91×	0.11×	0.0%	3	-348.91	2	C
Peer median	—	-2.72×	-1.07×	0.28×	-2.15×	-266.6%	0.0%	0.0%	-1.2%	4.7%	-11.2%	-16.9%	-0.03×	0.19×	-11.44×	0.84×	0.0%	3	-42.67	2	—